Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Changzhou Pharmaceutical Co., Ltd. (hereinafter referred to as “Changzhou Pharmaceutical Factory”) received the “Drug Registration Certificate” (certificate numbers: 2026S03419, 2026S03420) issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for esomeprazole magnesium enteric capsules (hereinafter referred to as “this drug”).

Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) issued an announcement. Recently, Changzhou Pharmaceutical Co., Ltd. (hereinafter referred to as “Changzhou Pharmaceutical Factory”) received the “Drug Registration Certificate” (certificate numbers: 2026S03419, 2026S03420) issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for esomeprazole magnesium enteric capsules (hereinafter referred to as “this drug”).